Sarah B. Goldberg on New Immunotherapy Options for Patients With Lung Cancer

Older patients with cancer demonstrated a moderate to high symptom burden, leading to the need for routine symptom assessments and tailored management interventions.

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

Alectinib was approved for the treatment of patients with ALK-positive non-small cell lung cancer after surgical resection.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Over the last 5 years, 57% of drugs approved by the FDA for a cancer-related indication did not show a clinical benefit in confirmatory studies.

Oncology nurses provide patients with lung cancer the education and empathy needed to navigate treatment options and adverse event management.